Tags : Denali Therapeutics


AbCellera and Denali Therapeutics Expand Collaboration to Develop Abs for

Shots:  AbCellera to receive technology access fee, milestones and royalties on the development and commercialization of pre-cliniocal candidates & will develop Abs for Denali’s eight targets for neurological disorders On 12 Jun,2018 Denali therapeutics collaborated with AbCellera for its single-cell technology to develop hundreds of mAbs for neurodegenerative diseases  AbCellera’s single-cell screening technology is a […]Read More